EP2059225A1 - Compositions antitranspirantes et désodorisantes de potentiel irritatif réduit - Google Patents

Compositions antitranspirantes et désodorisantes de potentiel irritatif réduit

Info

Publication number
EP2059225A1
EP2059225A1 EP07847981A EP07847981A EP2059225A1 EP 2059225 A1 EP2059225 A1 EP 2059225A1 EP 07847981 A EP07847981 A EP 07847981A EP 07847981 A EP07847981 A EP 07847981A EP 2059225 A1 EP2059225 A1 EP 2059225A1
Authority
EP
European Patent Office
Prior art keywords
oil
skin
deodorant
composition
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07847981A
Other languages
German (de)
English (en)
Inventor
Armin Wadle
Bernhard Banowski
Barbara Heide
Thomas Döring
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of EP2059225A1 publication Critical patent/EP2059225A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Definitions

  • the present application relates to cosmetic and dermatological antiperspirant and deodorant compositions which have a reduced irritation potential.
  • antiperspirant compositions hereinafter also referred to as antiperspirants, contain as antiperspirant active ingredient at least one water-soluble astringent inorganic and organic salts of aluminum, zinc or selected aluminum-zirconium mixed salts.
  • deodorant compositions also referred to below as deodorants, frequently contain at least one antibacterial active substance as the deodorant active ingredient.
  • the antiperspirant active ingredients have no direct influence on the activity of the sweat glands, but minimize the narrowing of the discharge channels sweat secretion.
  • the AI salts cause thereby on the treated skin surfaces a sweat inhibition by superficial blockage of the sweat gland ducts as a result of Al-Mucopolysaccharid precipitation.
  • Antiperspirant and deodorant compositions are usually applied and applied in the armpit area.
  • the armpit skin has a weak barrier function due to its location and function.
  • the skin in the underarm area is therefore more sensitive than the rest of the skin, often at least as sensitive as the skin of the face.
  • Many consumers consider a hairless armpit skin to be more aesthetically pleasing and hygienic, as hair growth increases the sweat-bearing surface in the armpit area and thus contributes to an increased body odor development. Accordingly, a regular shave of underarm hair is part of the routine of hygiene for many consumers.
  • the underarm shave mechanically irritates the skin and additionally weakens the barrier function.
  • a sweat-inhibiting and / or deodorizing cosmetic for example as a deodorant spray or deodorant stick, is usually applied to the underarm skin.
  • the antiperspirant and / or deodorant active ingredients have, for example, due to their acidic pH, usually a considerable irritation potential, which can cause reddening of the skin on the - mechanically irritated - armpit skin, an unpleasant burning, feeling of tension and / or itching.
  • the object of the present invention was to find active substances and / or carriers for cosmetic and dermatological antiperspirant and deodorant compositions with particularly high skin tolerance.
  • a further object of the present invention was to find active substances and / or carriers for cosmetic and dermatological antiperspirant and deodorant compositions with particularly high skin compatibility, in particular for mechanically irritated skin.
  • a further object of the present invention was to find active substances and / or carriers for cosmetic and dermatological antiperspirant and deodorant compositions which can make the skin-irritant antiperspirant and deodorant active ingredients more skin-friendly or can alleviate their irritative effect.
  • a further object of the present invention was to find active substances and / or carriers for cosmetic and dermatological antiperspirant and deodorant compositions which reduce the burning and / or itching of the skin when applied.
  • taurine and its physiologically tolerated salts, esters and amides solve the stated objects.
  • a subject of the present application is therefore a cosmetic or dermatological deodorant or antiperspirant composition, comprising in a cosmetically or dermatologically acceptable carrier at least one deodorant or antiperspirant active ingredient and at least one active ingredient selected from taurine and its physiologically acceptable salts, esters and Amides, as well as mixtures thereof.
  • Another object of the present application is the use of at least one active ingredient selected from taurine and its physiologically acceptable salts, esters and amides, and mixtures thereof, in a cosmetically or dermatologically acceptable carrier, containing at least one deodorant or antiperspirant active ingredient, for Improvement of the skin compatibility and / or the care effect of the composition and / or to reduce or avoid Skin burning, a feeling of tightness, itching and / or visible irritations, such as skin redness, which is / are caused by contact of the skin with the composition.
  • Another object of the present application is a non-therapeutic method for reducing or preventing skin burning and / or itching, which is caused by contact of the skin with the composition, characterized in that a composition according to the invention according to one of claims 1-9 Skin, especially the armpit skin, is applied.
  • a further preferred embodiment of the invention is characterized in that the active ingredient is an NC 2 -C 24 -acyl derivative of taurine or a taurine ester.
  • the C 2 -C 24 -acyl radical with which the taurine or the taurine ester is derivatized at the amino group is preferably selected from an acetyl, propanoyl, butanoyl, pentanoyl, hexanoyl, heptanoyl, octanoyl -, nonanoyl, decanoyl, undecanoyl, lauroyl, tridecanoyl, myristoyl, pentadecanoyl, cetoyl, palmitoyl, stearoyl, elaidoyl, arachidoyl or behenoyl radical.
  • Mixtures of C 8 -C 18 acyl radicals are also referred to as cocoyl radical and are likewise preferred substituents.
  • a further preferred embodiment of the invention is characterized in that the taurine or NC 2 -C 24 acyl derivative of taurine with the aforementioned C 2 - C 24 acyl radicals esterified to the acid group of taurine.
  • a further preferred embodiment of the invention is characterized in that the taurine or NC 2 -C 24 acyl derivative of taurine with the aforementioned C 2 - C 24 acyl radicals is linked at the amino group of taurine via an amide bond.
  • a further preferred embodiment of the invention is characterized in that the taurine is not present as a cationized derivative. Such derivatizations can not lead to a reduction in irritation contrary to the teaching of the present application.
  • the taurine substituted with the abovementioned C 2 -C 24 -acyl radicals can have a further improvement in the anti-irritant effect compared with the unsubstituted taurine.
  • a further preferred embodiment of the invention is characterized in that the taurine or the at least one NC 2 -C 24 -acyl derivative of taurine is in the form of at least one physiologically acceptable salt.
  • Physiologically acceptable salts of the invention preferred Taurine or NC 2 -C 24 acyl derivative of taurine are selected from the ammonium, alkali metal, magnesium, calcium, aluminum, zinc and manganese salts. Particularly preferred according to the invention are the sodium, potassium, magnesium, aluminum, zinc and manganese salts.
  • a further preferred embodiment of the invention is characterized in that the at least one active ingredient selected from taurine and its physiologically acceptable salts, esters and amides, and mixtures thereof, in a total amount of 0.001 to 3 wt .-%, preferably 0.01 - 2 wt .-%, more preferably 0.1 to 1, 5 wt .-% and most preferably 0.5 to 1 wt .-%, each based on the total composition is included.
  • preferred antiperspirant active substances are selected from aluminum chlorohydrates, especially aluminum chlorohydrates having the general formula [Al 2 (OH) 5 CI 2-3 ⁇ H 2 O] n, which may be present in non-activated or activated in (depolymerized) Form , furthermore aluminum sesquichlorohydrate, aluminum chlorohydrex-propylene glycol (PG) or polyethylene glycol (PEG), aluminum sesquichlorohydrex PG or PEG, aluminum PG-dichlorhydrex or aluminum PEG-dichlorhydrex, aluminum hydroxide, furthermore selected from the aluminum zirconium chlorohydrates, such as aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate , Aluminum zirconium pentachlorohydrate, aluminum zirconium octachlorohydrate, aluminum zirconium chlorohydrate glycine complexes such as aluminum zirconium trichlorohydrex glycine, aluminum zirconium
  • a solubility of at least 5 wt .-% at 20 0 C is understood according to the invention, solubility in water, that is, amounts of at least 5 g of the antiperspirant active ingredient in 95 g of water are soluble at 20 0 C.
  • the antiperspirant active ingredients can be used as aqueous solutions.
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that the at least one antiperspirant active ingredient is present in a total amount of 3 to 25 wt.%, Preferably 5 to 22 wt.% And in particular 10 to 20 wt. contained, based on the total weight of the active substance in the overall composition.
  • the amount of antiperspirant salt (s) indicated in the instant application is to be calculated according to the method of US Pharmacopoeia (USP), after which bound water of crystallization and other ligands, e.g. As glycine, are excluded.
  • the composition comprises an astringent aluminum salt, especially aluminum chlorohydrate, for example, in powder form as Micro Dry ® Ultrafine or Micro Dry ® SUF from Reheis, in the form of an aqueous solution as Locron ® L from Clariant, as Chlorhydrol ® as well as in activated form sold as Reach® 103 or Reach® 501 from Reheis. Under the name Reach® 301 an aluminum sesquichlorohydrate from Reheis is offered, which is likewise particularly preferred.
  • the use of aluminum zirconium tetrachlorohydrex glycine complexes which are, for example, by Reheis under the name Rezal ® 36G or Reach ® 908 commercially, may be particularly preferred according to the invention.
  • the compositions according to the invention may contain both at least one deodorant and at least one antiperspirant active.
  • Deodorant active ingredients which are preferred according to the invention are odor absorbers, deodorizing ion exchangers, germ-inhibiting agents, prebiotic active components and also enzyme inhibitors or, particularly preferred, combinations of said active substances.
  • Silicates serve as odor absorbers, which at the same time advantageously support the rheological properties of the composition according to the invention.
  • silicates particularly preferred according to the invention are, in particular, phyllosilicates and, among these, in particular montmorillonite, kaolinite, mit, beidellite, nontronite, saponite, hectorite, bentonite, smectite and talcum.
  • Other preferred odor absorbers are, for example, zeolites, Zinkricinoleat, cyclodextrins, certain metal oxides, such as. As alumina, and chlorophyll. They are preferably used in an amount of 0.1-10% by weight, more preferably 0.5-7% by weight and most preferably 1-5% by weight, based in each case on the overall composition.
  • germ-inhibiting or antimicrobial active ingredients are understood as meaning those active substances which reduce the number of skin germs participating in the formation of the odor or inhibit their growth.
  • These organisms include, among others, various species from the group of staphylococci, the group of Corynebacteria, anaerococci and micrococci.
  • Preferred antimicrobial or antimicrobial agents according to the invention are in particular organohalogen compounds and halides, quaternary ammonium compounds, a number of plant extracts and zinc compounds.
  • triclosan chlorhexidine and chlorhexi- dingluconate
  • 3,4,4'-trichlorocarbanilide bromochlorophene, dichlorophen, chlorothymol, chloroxylenol, hexachlorophene, dichloro-m-xylenol, dequalinium chloride, domiphenbromide, ammonium phenolsulfonate, benzalkonium halides, benzalkonium cetyl phosphate, benzalkonium saccharinates, benzethonium chloride, cetylpyridinium chloride, laurylpyridinium chloride, laurylisoquinolinium bromide , Methylbenzethonium chloride.
  • phenol phenoxyethanol, disodium dihydroxyethylsulfosuccinyl-cylindonate, sodium bicarbonate, zinc lactate, sodium phenolsulfonate and zinc phenolsulfonate, ketoglutaric acid, terpene alcohols such as.
  • chlorophyllin copper complexes ⁇ -monoalkyl glycerol ether with a branched or linear saturated or unsaturated, optionally hydroxylated C 6 - C 22 alkyl, particularly preferably ⁇ - (2-ethylhexyl) glycerol, commercially available as Sen- siva ® SC 50 (ex Schülke & Mayr), carboxylic acid esters of mono-, di- and triglycerol (eg glyceryl monolaurate, diglycerol monocaprinate), lantibiotics and plant extracts (eg green tea and components of lime blossom oil).
  • Sen- siva ® SC 50 Ex Schülke & Mayr
  • carboxylic acid esters of mono-, di- and triglycerol eg glyceryl monolaurate, diglycerol monocaprinate
  • lantibiotics and plant extracts eg green tea and components of lime blossom oil.
  • deodorant active substances are selected from so-called prebiotically active components, which according to the invention are to be understood as meaning those components which inhibit only or at least predominantly the odor-causing germs of the skin microflora, but not the desired ones, that is, the non-odor-forming germs that lead to a include healthy skin microflora.
  • active substances which are disclosed in the published patent applications DE 10333245 and DE 10 2004 011 968 as being prebiotically effective; These include conifer extracts, in particular from the group of Pinaceae, and plants extra kte from the group of Sapindaceae, Araliaceae, Lamiaceae and Saxifragaceae, in particular extracts of Picea spp., Paullinia sp., Panax sp., Lamium album or Ribes nigrum and mixtures thereof substances. Further preferred deodorant active ingredients are selected from the germ-inhibiting active perfume oils and Deosafe ® -Par colmölen that, Haarmann and Reimer, by the company Symrise previously available.
  • the enzyme inhibitors include substances which inhibit the enzymes responsible for the sweat decomposition, in particular the arylsulfatase, .beta.-glucuronidase, aminoacylase, esterases, lipases and / or lipoxygenase, eg. B. trialkylcitric acid, in particular triethyl citrate, or zinc glycinate.
  • Preferred deodorant or antiperspirant compositions according to the invention are characterized in that the at least one deodorant active ingredient is selected from arylsulfatase inhibitors, ⁇ -glucuronidase inhibitors, aminoacylase inhibitors, esterase inhibitors, lipase inhibitors and lipoxigenase inhibitors.
  • Inhibitors ⁇ -Monoalkylglycerinethern with a branched or linear saturated or unsaturated, optionally hydroxylated C 6 - C 22 alkyl, especially ⁇ - (2-ethylhexyl) glycerol ether, phenoxyethanol, germ-inhibiting perfume oils, Deosafe ® -Ppar Stahl Stahl (Deosafe ® a registered trademark of Symrise, formerly Haarmann & Reimer), prebiotically active components, trialkyl citric acid esters, especially triethyl citrate, active substances Substances which reduce or inhibit the growth of the number of skin germs from the group of staphylococci, corynebacteria, anaerococci and micrococci, zinc compounds, in particular zinc phenolsulphonate and zinc ricinoleate, organohalogen compounds, in particular triclosan, chlorhexidine, chlorhexidine gluconate and benzalkonium halides, quaternary am
  • deodorant or antiperspirant compositions are characterized in that the at least one deodorant active ingredient is present in a total amount of 0.1-10% by weight, preferably 0.2-7% by weight, particularly preferably 0.3 - 5 wt .-% and most preferably 0.4 - 1, 0 wt .-%, each based on the total weight of the active substance of the deodorant active ingredient or the deodorant active ingredients in the overall composition is included.
  • compositions according to the invention may contain both at least one deodorant and at least one antiperspirant active.
  • cosmetically or dermatologically acceptable carrier is present as powder, in stick form, as aerosol spray, pump spray, liquid or gel roll-on application, cream, lotion, solution, gel or on a substrate.
  • Deodorant or antiperspirant sticks can be in gelled, anhydrous, based on a W / O emulsion, based on an O / W emulsion, based on a water-oil multiple emulsion, based on a nanoemulsion and on Basis of a microemulsion, wherein the oil phase contain at least one silicone component or may consist of at least one silicone component.
  • the compositions according to the invention, which are formulated as deodorant or antiperspirant sticks can be prepared on anhydrous fat basis, based on a polyol-in-oil emulsion based on an oil-in-polyol emulsion based on a polyol oil.
  • Gel sticks may be formulated on the basis of fatty acid soaps, alditols, especially dibenzylidenesorbitol, N-acylamino acid amides, 12-hydroxystearic acid, polyamides, polyamide derivatives, polysaccharides such as xanthan, polyglucomannans, guar, konjac, celluloses or starches, polyacrylates, polyacrylate derivatives and other gelling agents.
  • Aerosol sprays, pump sprays, roll-on applications and creams may be in the form of a water-in-oil emulsion, water-in-silicone oil emulsions, oil-in-water emulsion, silicone oil-in-water emulsion, water-in-oil Microemulsion, oil-in-water microemulsion, silicone oil-in-water microemulsion, polyol-in-oil emulsion, oil-in-polyol emulsion, polyol-oil multiple emulsion, anhydrous suspension, preferably anhydrous oil-based suspension , alcoholic solution, in particular ethanolic solution, hydroalcoholic solution, in particular solutions with more than 50 wt .-% of a water-ethanol mixture, glycolic solution, especially as a solution in propylene glycol, glycerol, dipropylene glycol and (under normal conditions) liquid polyethylene glycols, hydroglycolic solution , Polyol solution, water-polyol solution
  • compositions may be thickened, for example, based on fatty acid soaps, dibenzylidenesorbitol, N-acylamino acid amides, 12-hydroxystearic acid, carbomer and carbopol type polyacrylates, polyacrylamides and polysaccharides, which may be chemically and / or physically modified.
  • the compositions may be transparent, translucent or opaque.
  • compositions according to the invention be in the form of a pin, they contain a wax matrix preferably comprising at least one wax component with a melting point of> 50 0 C.
  • waxes of solid to brittle hard consistency coarse to fine crystalline, translucent to opaque, but not glassy, and melt above 50 0 C without decomposition. They are already slightly above the melting point low viscosity and show a strong temperature-dependent consistency and solubility.
  • Preference according to the invention for example, natural vegetable waxes, z. Candelilla wax, carnauba wax, Japan wax, sugarcane wax, ouricoury wax, cork wax, sunflower wax, fruit waxes such as orange waxes, lemon waxes, grapefruit wax, and animal waxes, e.g. Beeswax, shellac wax and spermaceti.
  • it may be particularly preferred to use hydrogenated or hardened waxes.
  • a wax component and chemically modified waxes especially the hard waxes, such as.
  • montan ester waxes hydrogenated jojoba waxes and Sasol waxes used.
  • Synthetic waxes which are also preferable in the invention include, for example, polyalkylene waxes and polyethylene glycol waxes, C 2 oC 4O dialkyl esters of dimer acids, C 30 - 50 alkyl and alkylaryl esters of -Alkylbienenwachs and dimer fatty acids.
  • a particularly preferred wax component is selected from at least one ester of a saturated monohydric C 6 -C 6 -alcohol and a saturated Cs-Cs ⁇ -monocarboxylic acid.
  • lactides the cyclic double esters of ⁇ -hydroxycarboxylic acids of the corresponding chain length, also belong thereto.
  • Esters of fatty acids and long-chain alcohols have proven to be
  • the composition according to the invention has proved to be particularly advantageous because it gives the antiperspirant preparation excellent sensory properties and pins a high stability.
  • the esters are composed of saturated branched or unbranched monocarboxylic acids and saturated branched or unbranched monohydric alcohols.
  • esters of aromatic carboxylic acids and hydroxycarboxylic acids eg., 12-hydroxystearic acid
  • saturated branched or unbranched alcohols are used according to the invention, provided that the wax component has a melting point of> 50 0 C. It is particularly preferred to choose the wax components from the group of esters of saturated branched or unbranched alkanecarboxylic acids having a chain length of 12 to 24 carbon atoms and the saturated branched or unbranched alcohols having a chain length of 16 to 50 carbon atoms and having a melting point> 50 0 C have.
  • the wax component C 6-36 alkyl stearates and C- ⁇ 8 - 38 -Alkylhydroxystearoylstea- rate C 2 o 4 o-Alkylerucate and cetearyl be advantageous.
  • the wax or the wax components have a melting point> 50 ° C, preferably> 60 0 C, on.
  • a particularly preferred embodiment of the invention in stick form contains as wax component a C 2 oC 4 o-alkyl stearate.
  • This ester is known under the name Kester ® ® K82H or Kesterwachs K80H, sold by Koster Keunen Inc.. It is the synthetic imitation of the monoester fraction of beeswax and is characterized by its hardness, oil gelability and broad compatibility with lipid components.
  • This wax can be used as a stabilizer and consistency regulator for W / O and O / W emulsions.
  • Kester wax has the advantage that it has an excellent oil gelability even at low concentrations and so does not make the pencil mass too heavy and allows a velvety abrasion.
  • Another particularly preferred embodiment of the invention in stick form contains as wax component cetearyl behenate, ie mixtures of cetyl behenate and stearyl behenate.
  • This ester is known under the name Kester ® K62 and is sold by Koster Keunen Inc..
  • More preferred wax components with a melting point of> 50 0 C are the triglycerides of saturated and optionally hydroxylated C 12 - 3 o-fatty acids such as hydrogenated triglyceride fats (hydrogenated palm oil, hydrogenated coconut oil, hydrogenated castor oil), glyceryl tribehenate (tribehenin), or glyceryl tri-12-hydroxystearate, further synthetic Vollester of fatty acids and glycols or polyols containing 2 - 6 carbon atoms as long as they have a melting point above 50 0 C, for example, preferably C 8 - C 36 acid triglyceride (Syncrowax HGL-C ®).
  • the hydrogenated castor oil as a wax component available for example as a commercial product Cutina ® HR, is particularly preferred.
  • Preferred deodorant or antiperspirant compositions according to the invention are characterized by a content of wax component which is selected from esters of a saturated, monohydric C 12 -C 6 o-alkanol and a saturated Cs-Cs ⁇ monocarboxylic acid, in particular lauryl laurate, lauryl myristate, lauryl palmitate, lauryl stearate, lauryl-12-hydroxystearate, Lauryleicosanat, Laurylbehenat, Lauryllignocerat, Laurylcerat, Laurylmyricat, Myristyllaurat, myristyl myristate, myristyl palmitate, myristyl stearate, myristyl-12-hydroxystearate, Myristyleicosanat, Myristylbehenat, Myristyllignocerat, Myristylcerat, Myristylmyricat, cetyl laurate
  • wax components are selected from saturated linear C 14 - C 36 carboxylic acids, in particular myristic, palmitic, stearic, 12-hydroxystearic, eicosanoic, behenic, lignoceric, ceric, myric, and mixtures of the aforementioned acids.
  • Particularly preferred wax component blends are selected from mixtures of cetyl behenate, stearyl behenate, hardened castor oil, palmitic acid and stearic acid.
  • Further particularly preferred wax component mixtures are selected from mixtures comprising C 2 -C 4 -alkyl stearate, hydrogenated castor oil, palmitic acid and stearic acid.
  • wax component mixtures are selected from mixtures comprising C 6 -C 2 o-Alkylbehenat, hydrogenated castor oil, palmitic acid and stearic acid.
  • Further particularly preferred wax component mixtures are selected from mixtures comprising arachyl stearate, behenyl stearate, lignoceryl stearate, ceryl stearate, myricyl stearate, hydrogenated castor oil, palmitic acid and stearic acid.
  • Further particularly preferred wax component mixtures are selected from mixtures comprising palmityl behenate, stearyl behenate, arachyl behenate, hardened castor oil, palmitic acid and stearic acid.
  • deodorant or antiperspirant compositions according to the invention are characterized in that the wax component (s) is generally added in amounts of 4 to 20% by weight, preferably 7 to 15% by weight, very preferably 10%. 12 wt .-%, each based on the total composition is included.
  • ester (s) of a saturated monohydric C 2 -C 6 o -alkanol and a saturated C 8 -C 36 monocarboxylic acid which constitutes the wax component (s) are / are in total amounts 2-10 wt .-%, preferably 2-6 wt .-%, most preferably 3-5 wt .-%, each based on the total composition.
  • Oil-in-water emulsifiers oil-in-water emulsifiers
  • compositions according to the invention which are formulated as an emulsion, in particular as an oil-in-water emulsion or a polyol-in-water emulsion, preferably contain at least one nonionic oil-in-water emulsifier having an HLB value of more as 7.
  • nonionic oil-in-water emulsifier having an HLB value of more as 7.
  • nonionic oil-in-water emulsifiers which are suitable according to the invention, it is particularly preferable to use a mixture of nonionic oil-in-water emulsifiers in order to optimally adjust the stability of O / W emulsion compositions according to the invention.
  • the individual emulsifier components deliver a proportion to the total HLB value or mean HLB value of the oil-in-water emulsifier mixture in accordance with their proportion of the total amount of oil-in-water emulsifiers.
  • the average HLB value of the oil-in-water emulsifier mixture is 10-19, preferably 12-18 and particularly preferably 14-17.
  • oil-in-water emulsifiers preference is given to oil-in-water emulsifiers from the HLB value ranges 10 - 14, 14 - 16 and possibly 16 - 19 combined.
  • the oil-in-water emulsifier mixtures may also contain nonionic emulsifiers with HLB values in the range of> 7-10 and 19-20; Such emulsifier mixtures may also be preferred according to the invention.
  • the deodorant or antiperspirant compositions of the present invention may also contain only a single oil-in-water emulsifier having an HLB in the range of 10-19.
  • Preferred deodorant or antiperspirant compositions according to the invention are characterized in that the nonionic oil-in-water emulsifiers are selected from ethoxylated C 8 -C 24 -alkanols with an average of 10 to 100 moles of ethylene oxide per mole of ethoxylated C 8 -C 24 - Carboxylic acids containing on average 10-100 moles of ethylene oxide per mole, silicone copolyols having ethylene oxide units or with ethylene oxide and propylene oxide units, alkyl mono- and oligoglycosides having 8 to 22 carbon atoms in the alkyl radical and their ethoxylated analogs, ethoxylated sterols , Partial esters of polyglycerols having 2 to 10 glycerol units and esterified with 1 to 4 saturated or unsaturated, linear or branched, optionally hydroxylated C 8 - C 30 fatty acid residues, if they have an HLB value of more
  • the ethoxylated C 8 -C 24 -carboxylic acids have the formula R 1 (OCH 2 CH 2 ) n OH, where R 1 is a linear or branched saturated or unsaturated acyl radical having 8-24 carbon atoms and n, the average number of ethylene oxide units per molecule, for numbers from 10 to 100, preferably 10 to 30, mol of ethylene oxide to 1 mol of caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, cetylic acid, palmitoleic acid, stearic acid, isostearic acid, Oleic acid, elaidic acid, petroselinic acid, arachidic acid, gadoleic acid, behenic acid, erucic acid and brassidic acid and their technical mixtures.
  • Adducts of 10 to 100 mol of ethylene oxide with technical fatty acids containing 12 to 18 carbon atoms, such as coconut, palm, palm kernel or tallow fatty acid, are also suitable. Particularly preferred are PEG-50 monostearate, PEG-100 monostearate, PEG-50 monooleate, PEG-100 monooleate, PEG-50 monolaurate and PEG-100 monolaurate.
  • C 2 -C 8 -alkanols or C 2 -C 8 carboxylic acids each having 10 to 30 units of ethylene oxide per molecule and mixtures of these substances, in particular ceteth-12, ceteth-20, ceteth-30, lsoceteth- 20, steareth-12, steareth-20, steareth-30, ceteareth-12, ceteareth-20, ceteareth-30, laureth-12 and beheneth-20.
  • C 8 -C 22 -alkyl mono- and -oligoglycosides preference is given to using C 8 -C 22 -alkyl mono- and -oligoglycosides.
  • C 8 -C 22 -alkyl mono- and oligoglycosides are known, commercially available surfactants and emulsifiers. They are prepared in particular by reacting glucose or oligosaccharides with primary alcohols having 8-22 carbon atoms.
  • the glycoside radical monoglycosides in which a cyclic sugar residue is glycosidically linked to the fatty alcohol and oligomeric glycosides having a degree of oligomerization of up to about 8, preferably 1-2, are suitable.
  • the degree of oligomerization is a statistical mean value based on a homolog distribution which is customary for such technical products.
  • Particularly preferred C 8 -C 22 alkyl mono- and oligoglycosides are selected from octyl glucoside, decyl glucoside, lauryl glucoside, palmityl glucoside, isostearyl glucoside, stearyl glucoside, arachidyl glucoside and behenyl glucoside and mixtures thereof.
  • the glucamine-derived acylglucamides are also suitable as nonionic oil-in-water emulsifiers.
  • Ethoxylated sterols in particular ethoxylated soy sterols, are also suitable oil-in-water emulsifiers according to the invention.
  • the degree of ethoxylation must be greater than 5, preferably at least 10, in order to have an HLB value greater than 7.
  • Suitable commercial products are, for. PEG-10 Soy Sterol, PEG-16 Soy Sterol and PEG-25 Soy Sterol.
  • diglycerol monocaprylate diglycerol monocaprate, diglycerol monolaurate, triglycerol monocaprylate, triglycerol monocaprate, triglycerol monolaurate, tetraglycerol monocaprylate, tetraglycerol monocaprate, tetraglycerol monolaurate, pentaglycerol monocaprylate, pentaglycerol mono- caprate, glycerol monocaprate Pentaglycerinmonolaurat, Hexaglycerinmonocaprylat, Hexaglycerinmonocaprat, hexa glycerol monolaurate, Hexaglycerinmonomyristat, Hexaglycerinmonostearat, Decaglycerinmonocaprylat, deca-, decaglyceryl monolaurate, decaglyceryl monomyristate, Decaglycerinmonoisostea- rat
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that the nonionic oil-in-water emulsifier in a total amount of 0.5 to 10 wt .-%, particularly preferably 1 to 4 wt .-% and most preferably 1 , 5 - 3 wt .-%, based on the total composition is included.
  • compositions according to the invention which are formulated as an emulsion or stick, preferably furthermore comprise at least one nonionic water-in-oil emulsifier having an HLB value greater than 1.0, and less than or equal to 7.0, selected from the mono- and diesters of Ethylene glycol and the mono-, di-, tri- and tetra-esters of pentaerythritol with linear saturated fatty acids having 12-30, in particular 14-22 carbon atoms, which may be hydroxylated, and mixtures thereof, as consistency regulator and / or water binder.
  • the mono- and diesters are preferred.
  • C 2 -C 30 fatty acid radicals preferred according to the invention are selected from lauric acid, myristic acid, palmitic acid, stearic acid, arachic acid and behenic acid radicals; particularly preferred is the stearic acid residue.
  • Particularly preferred nonionic water-in-oil emulsifiers according to the invention having an HLB value greater than 1.0 and less than or equal to 7.0 are selected from pentaerythrityl monostearate, pentaerythrityl distearate, pentaerythrityl tristearate, pentaerythrityl tetrastearate, ethylene glycol monostearate, ethylene glycol distearate and mixtures thereof.
  • particularly preferred water-in-oil emulsifiers having an HLB value greater than 1, 0 and less than / equal to 7.0, for example as commercial products Cutina ® PES (INCI: Pentaerythrityl distearate), Cutina ® AGS (INCI: distearate Glycol) or Cutina ® EGMS (INCI: glycol stearate) available.
  • Cutina ® PES INCI: Pentaerythrityl distearate
  • Cutina ® AGS INCI: distearate Glycol
  • Cutina ® EGMS INCI: glycol stearate
  • compositions according to the invention comprise mixtures, in particular technical mixtures, of at least two water-in-oil emulsifiers.
  • a commercial product such as Cutina ® PES is meant, for example, a technical mixture.
  • at least one further nonionic water-in-oil emulsifier having an HLB value greater than 1, 0 and less than or equal to 7, 0 should be included, the proportion of the total weight of nonionic water-in-oil emulsifiers with an HLB value greater than 1, 0 and less than or equal to 7.0 preferably, but should not be greater than 80%.
  • compositions according to the invention contain the at least one additional water-in-oil emulsifier having an HLB value greater than 1.0, and less than or equal to 7.0 only in a proportion by weight of not more than 10% or are free of additional water in oil emulsifiers.
  • additional suitable emulsifiers are listed, for example, in Kirk-Othmer, "Encyclopedia of Chemical Technology” 3rd Ed., 1979, Vol. 8, page 913.
  • the HLB value can also be calculated.
  • Suitable water-in-oil emulsifiers are preferably: linear saturated alkanols having 12 to 30 carbon atoms, in particular 16 to 22 carbon atoms, in particular cetyl alcohol, stearyl alcohol, arachidyl alcohol, behenyl alcohol and lanolin alcohol or mixtures of these alcohols, as used in the industrial hydrogenation of vegetable and animal fatty acids are available,
  • Such esters or partial esters are, for.
  • the mono- and diesters of glycerol or monoesters of propylene glycol with linear saturated and unsaturated C 12 - C 30 carboxylic acids which may be hydroxylated, especially those with palmitic and stearic
  • the sorbitan mono-, -di- or triesters of linear saturated and unsaturated C 12 -C 30 carboxylic acids which may be hydroxylated, in particular those of myristic acid, palmitic acid, stearic acid or mixtures of these fatty acids and the methyl glucose mono- and diesters of linear saturated and unsaturated C 12 -C 30 -Carboxylic acids which may be hydroxylated
  • Sterols, ie steroids which carry a hydroxyl group at the C3 atom of the steroid skeleton and both from animal tissue (zoosterols, eg cholesterol, lanosterol) as well as from plants (phytosterols, eg ergosterol, stigmasterol, sitosterol
  • Alkanols and carboxylic acids each having 8-24 C atoms, in particular having 16-22 C atoms, in the alkyl group and 1-4 ethylene oxide units per molecule which have an HLB value of greater than 1.0, and less than or equal to 7.0 exhibit,
  • Partial ester of polyglycerols having n 2 to 10 glycerol units and esterified with 1 to 5 saturated or unsaturated, linear or branched, optionally hydroxylated C 8 - C 30 fatty acid residues, if they have an HLB value of 7 or less, and mixtures of aforementioned substances.
  • compositions according to the invention comprise mixtures, in particular technical mixtures, of at least two additional water-in-oil emulsifiers.
  • a commercial product such as Cutina GMS ® is understood to be a technical mixture, which is a mixture of glyceryl monostearate and glyceryl distearate.
  • Particularly advantageous additional water-in-oil emulsifiers are stearyl alcohol, cetyl alcohol, glyceryl monostearate, in particular in the form of the commercial products Cutina ® GMS and Cutina ® MD (ex Cognis), glyceryl distearate, glyceryl monocaprinate, glyceryl monocaprylate, glyceryl monolaurate, glyceryl monomyristate, glyceryl monopalmitate, glyceryl monohydroxystearate , glyceryl monooleate, glyceryl rylmonolanolat, Glyceryldimyristat, Glyceryldipalmitat, glyceryl dioleate, propylene glycol monostearate, pro pylenglycolmonolaurat, sorbitan monocaprylate, sorbitan monolaurate, sorbitan monomyristate, sorbitan monopalmitate
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that at least one water-in-oil emulsifier is present in a total amount of 0.1-15% by weight, preferably 0.5-8.0% by weight, and particularly preferably 1 to 4 wt .-%, based on the total composition, are included. Furthermore, amounts of 2-3-3.5% by weight, based on the total weight of the composition, according to the invention may also be extremely preferred.
  • W / O emulsifiers are silicone-free polymeric water-in-oil emulsifiers, in particular PEG-30 dipolyhydroxystearate, available for. B. under the trade name Arlacel P 135 from Uniqema.
  • this emulsifier can be formulated low-viscous and even sprayable water-in-oil emulsions.
  • Compositions which are particularly preferred according to the invention and which are formulated as a water-in-oil emulsion preferably furthermore comprise at least one water-in-oil emulsifier based on silicone.
  • the at least one silicone-based water-in-oil emulsifier is preferably present in an amount of from 0.5 to 5% by weight, more preferably from 0.1 to 1.5 to 2.5 to 3.5% by weight. %, in each case based on the total weight of the emulsion.
  • PEG / PPG-18/18 dimethicones which are commercially available in a 1: 9 mixture with cyclomethicone as DC 3225 C or DC 5225 C
  • PEG / PPG-4/12 dimethicone sold under the name Abil B 8852 is available as well as Bis-PEG / PPG-14/14 Dimethicone, which is commercially available in a mixture with Cyclomethicone as Abil EM 97 (Goldschmidt)
  • Bis-PEG / PPG-20/20 Dimethicone under the name Abil B 8832 is available, PEG / PPG-5/3 trisiloxanes (Silsoft 305), and PEG / PPG-20/23 dimethicones (Silsoft 430 and Silsoft 440).
  • silicone-based w / o emulsifiers which are preferred according to the invention are poly (C 2 -C 3 ) -alkylene glycol-modified silicones which are hydrophobically modified with C 4 -C 18 -alkyl groups, particularly preferably cetyl PEG / PPG-10/1 Dimethicone (formerly: cetyl dimethicone copolyol, available as Abil EM 90 or in a mixture of polyglyceryl-4-isostearate, cetyl PEG / PPG-10/1 dimethicone and hexyl laurate under the trade name Abil WE 09), furthermore alkyl methicone copolyols and Alkyl dimethicone ethoxy glucosides.
  • poly (C 2 -C 3 ) -alkylene glycol-modified silicones which are hydrophobically modified with C 4 -C 18 -alkyl groups, particularly preferably cetyl PEG / PPG-10/1
  • HLB values can also be calculated according to Griffin, as described, for example, in the R ⁇ MPP Chemie Lexikon, in particular in the online version of November 2003, and the manuals cited there under the heading "HLB system" by Fiedler, Kirk-Othmer and If there is different information on the HLB value of a substance in the literature, the HLB value for the teaching according to the invention which comes closest to the value calculated according to Griffin should be used can not find a unique HLB value, is the HLB value, indicates the manufacturer of the emulsifier to use for the teaching of the invention. If this is not possible, the HLB value must be determined experimentally.
  • polyoxyethylene (2) oleyl alcohol polyoxyethylene (2) oleyl ether
  • polyoxyethylene (2) stearyl alcohol polyoxyethylene (2) stearyl ether
  • Polyglyceryl-3-isostearates eg Isolan Gl 34 from Tego
  • Polyoxyethylene (2) C 10 -C 14 fatty alcohol ether, Laureth-2 (Dehydol LS 2)
  • PEG-40 Castor OiI eg Eumulgin RO 40
  • decylglucoside Oramix NS 10
  • Dodecylglucoside Planten APG 600
  • Dodecyltrimethylammonium chloride Nonylphenol ethoxylated with 15 moles EO
  • Polyethylene glycol 1000
  • Monostearate Polyoxyethylene 600
  • Monooleate 15-17 Eumulgin HRE 60 (castor oil, ethoxylated with 60 EO and hydrogenated)
  • compositions according to the invention are characterized in that the total content of nonionic and ionic emulsifiers and / or surfactants having an HLB value of more than 8 not more than 20 wt.%, Preferably not more than 15 wt.%, Particularly preferably not more than 10 wt. , particularly preferably at most 7 wt .-%, more preferably at most 4 wt .-% and most preferably at most 3 wt .-%, each based on the total composition of the invention is. oils
  • compositions according to the invention which are in the form of an emulsion, suspension, anhydrous suspension or stick, preferably further contain at least one oil which is liquid at 20 ° C. and which does not constitute a fragrance component and does not represent an essential oil.
  • Oils preferred according to the invention are selected from branched saturated or unsaturated fatty alcohols having 6 to 30 carbon atoms. These alcohols are also often referred to as Guerbet alcohols, as they are obtainable by the Guerbet reaction.
  • Preferred alcohol oils are Hexyldecanol (Eutanol ® G 16, Guerbitol ® T 16) Octyldodecanol (Eutanol ® G, Guerbitol ® 20), 2-ethylhexyl alcohol and the commercial products Guerbitol ® 18, Isofol ® 12, Isofol ® 16, Isofol ® 24, Isofol ® 36, Isocarb 12 ®, ® Isocarb 16 or Isocarb ® 24.
  • Further preferred oil components are mixtures of Guerbet alcohols and Guerbet alcohol esters, for example the commercial product Cetiol ® PGL (hexyldecanol and hexyldecyl laurate). Further oils preferred according to the invention are selected from the triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C 8 . 3 o-fatty acids.
  • Particularly suitable may be the use of natural oils, for example soybean oil, cottonseed oil, sunflower oil, palm oil, palm kernel oil, linseed oil, almond oil, castor oil, corn oil, olive oil, rapeseed oil, sesame oil, thistle oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil and the like.
  • natural oils for example soybean oil, cottonseed oil, sunflower oil, palm oil, palm kernel oil, linseed oil, almond oil, castor oil, corn oil, olive oil, rapeseed oil, sesame oil, thistle oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil and the like.
  • synthetic triglyceride oils in particular Capric / Caprylic triglycerides, z.
  • Myritol ® 318 Myritol ® 331 (Cognis) or Miglyol ® 812 (Hüls) with unbranched fatty acid residues and glyceryl triisostearin
  • Estol ® GTEH 3609 Uniqema
  • Myritol ® GTEH Cognis
  • diisopropyl adipate di-n-butyl adipate
  • di (2-ethylhexyl) adipate dioctyl adipate
  • particularly preferred oils are selected from the addition products of from 1 to 5 propylene oxide units onto mono- or polyhydric C 8-22 alkanols, such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, eg. B. PPG-2 myristyl ether and PPG-3-myristyl ether (Witconol APM ®).
  • mono- or polyhydric C 8-22 alkanols such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, eg. B. PPG-2 myristyl ether and PPG-3-myristyl ether (Witconol APM ®).
  • Further oil components preferred according to the invention are selected from the esters of linear or branched saturated or unsaturated fatty alcohols having 2 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2 to 30 carbon atoms which may be hydroxylated.
  • These include, hexyldecyl stearate (Eutanol ® G 16 S), hexyldecyl, Isodecylneopen- tanoat, isononyl isononanoate, 2-ethylhexyl palmitate (Cegesoft ® C 24) and 2-ethylhexyl stearate (Cetiol ® 868).
  • oil components are selected from the addition products of at least 6 ethylene oxide and / or propylene oxide units of mono- or polyhydric C 3 _ 22 - alkanols such as butanol, butanediol, myristyl alcohol and stearyl alcohol, eg. As PPG-14 butyl ether (Ucon Fluid ® AP), PPG-9-butyl ether (Breox B25 ®), PPG-10 butanediol (Macol ® 57) and PPG-15 stearyl ether (Arlamol ® E).
  • PPG-14 butyl ether Ucon Fluid ® AP
  • PPG-9-butyl ether Breox B25 ®
  • PPG-10 butanediol Macol ® 57
  • PPG-15 stearyl ether Arlamol ® E
  • Further oil components preferred according to the invention are selected from the C 8 -C 22 -fatty alcohol esters of monohydric or polyhydric C 2 -C 7 -hydroxycarboxylic acids, in particular the esters of glycolic acid, lactic acid, malic acid, tartaric acid, citric acid and salicylic acid.
  • Ci 2 -C 15 -alkyllactate, and of branched in the 2-position C 12 / i 3 alkanols are under the trademark Cosmacol ® by the company Nordmann, Rassmann GmbH & Co, Hamburg, refer, in particular the commercial products Cosmacol ® ESI, Cosmacol® ® EMI and Cosmacol® ® EIT.
  • oil components are selected from the symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, eg. As glycerol carbonate, dicaprylyl (Cetiol ® CC) or the esters of DE 197 56 454 A1.
  • Further preferred oil components according to the invention are selected from the esters of dimers of unsaturated C 12 -C 22 -fatty acids (dimer fatty acids) with monovalent linear, branched or cyclic C 2 -C 18 -alkanols or with polyvalent linear or branched C 2 -C 6 -alkanols. It may be extraordinarily preferred according to the invention to use mixtures of the abovementioned oils.
  • oil components preferred according to the invention are selected from silicone oils and hydrocarbon oils.
  • Silicone oils preferred according to the invention are selected from dialkyl and alkylaryl siloxanes, which include, for example, dimethylpolysiloxane and methylphenylpolysiloxane, but also hexamethyldisiloxane, octamethyltrisiloxane and decamethyltetrasiloxane.
  • silicone oils are selected from volatile silicone oils which may be cyclic, such as.
  • volatile silicone oils which may be cyclic, such as.
  • Dow Corning 200 (0.65 cSt) and Dow Corning® 200 (1.5 cSt) from Dow Corning.
  • silicone oils are selected from non-volatile higher molecular weight linear dimethylpolysiloxanes, commercially available z.
  • preferred natural and synthetic hydrocarbons are selected from paraffinic oils, isohexadecane, isoeicosane, polyisobutenes and polydecenes, the ®, for example, under the designation Emery ® 3004, 3006, 3010 or under the name Ethylflo ® from Albemarle or Nexbase 2004G from Nestle are available, as well as 1 , 3-di- (2-ethylhexyl) -cyclohexane (Cetiol ® S).
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that the oil (s) liquid at 20 ° C. in a total amount of 0.1-80% by weight, preferably 2-20% by weight, particularly preferably 3-15% by weight, in each case based on the total weight of the composition, is / are contained.
  • a proportion of the oil components of at least 80 wt .-%, a refractive index n D of 1, 39 - 1, 51 on. It is particularly preferred if 5 - 40 - 50 wt .-%, most preferably 10 - 12 - 25 - 30 wt .-% of the oil components have a refractive index n D of 1, 43 - 1, 58, preferably 1, 44 - 1 , 51, more preferably 1, 45 - 1, 47 - 1, 49, at 20 0 C (measured at ⁇ 589 nm) have.
  • Compositions which are particularly preferred according to the invention furthermore preferably contain at least one skin-cooling active substance.
  • Skin-cooling active ingredients suitable according to the invention are, for example, menthol, isopulegol and menthol derivatives, eg. Menthyl lactate, menthyl glycolate, menthyl pyrrolidone carboxylic acid, menthyl methyl ether, menthoxypropanediol, menthone glycerol acetal (9-methyl-6- (1-methylethyl) -1, 4-dioxaspiro (4.5) decane-2-methanol), monomethyl succinate and 2-hydroxymethyl-3 , 5.5-trimethylcyclohexanol.
  • Preferred skin-cooling active ingredients are menthol, isopulegol, menthyl lactate, menthoxypropanediol and menthylpyrrolidonecarboxylic acid, and mixtures of these substances, in particular mixtures of menthol and menthyl lactate, menthol, menthol glycolate and menthyl lactate, menthol and menthoxypropanediol or menthol and isopulegol.
  • At least one skin-cooling active compound prefferably be present in a total amount of 0.01-1% by weight, more preferably 0.02-0.5% by weight and most preferably 0.05-0.2-0.3% by weight %, in each case based on the total weight of the composition.
  • compositions which are particularly preferred according to the invention and which are to be used as propellant-driven aerosol contain at least one propellant.
  • propellants are Propane, propene, n-butane, isobutane, isobutene, n-pentane, pentene, iso-pentane, iso-pentene, methane, ethane, dimethyl ether, nitrogen, air, oxygen, nitrous oxide, 1, 1, 1, 3-tetrafluoroethane, heptafluoro-n-propane, perfluoroethane, monochlorodifluoromethane, 1,1-difluoroethane (INCI: hydrofluorocarbon 152a) both individually and in combination.
  • hydrophilic propellants such as carbon dioxide
  • hydrophilic propellants such as carbon dioxide
  • lipophilic propellant gas eg., Propane / butane
  • propane, n-butane, isobutane and mixtures of these propellants propane, n-butane, isobutane and mixtures of these propellants. It has been found that the use of n-butane as the only propellant gas according to the invention can be particularly preferred.
  • the amount of blowing agent is preferably 20-80-90% by weight, more preferably 30-70-75% by weight and most preferably 40-50% by weight, in each case based on the total weight of the preparation, consisting of the inventive composition Composition and the propellant.
  • compositions of the present invention sprayed with a propellant may either be packaged directly with the propellant or packaged in a multichamber container in which the composition of the present invention is physically separate from the propellant.
  • compositions according to the invention also comprise at least one water-soluble polyhydric C 2 -C 9 -alkanol having 2-6 hydroxyl groups and / or at least one water-soluble polyethylene glycol having 3-20 ethylene oxide units and mixtures thereof.
  • These components are preferably selected from 1,2-propylene glycol, 2-methyl-1,3-propanediol, glycerol, butylene glycols such as 1,2-butylene glycol, 1,3-butylene glycol and 1,4-butylene glycol, pentylene glycols such as 1, 2-pentanediol and 1, 5-pentanediol, hexanediols such as 1, 2-hexanediol and 1, 6-hexanediol, hexanetriols such as 1, 2,6-hexanetriol, 1, 2-octanediol, 1, 8-octanediol, dipropylene glycol, Tripropylene glycol, diglycerol, triglycerol, erythritol, sorbitol and mixtures of the aforementioned substances.
  • butylene glycols such as 1,2-butylene glycol, 1,3-butylene glycol and
  • Suitable water-soluble polyethylene glycols are selected from PEG-3, PEG-4, PEG-6, PEG-7, PEG-8, PEG-9, PEG-10, PEG-12, PEG-14, PEG-16, PEG-18 and PEG-20 and mixtures thereof, with PEG-3 to PEG-8 being preferred.
  • Preferred deodorant or antiperspirant compositions according to the invention are characterized in that the at least one water-soluble polyhydric C 2 -C 9 -alkanol having 2 to 6 hydroxyl groups and / or at least one water-soluble polyethylene glycol having 3 to 20 ethylene oxide units is selected from 1, 2 Propylene glycol, 2-methyl-1,3-propanediol, glycerin, butylene glycols such as 1,2-butylene glycol, 1,3-butylene glycol and 1,4-butylene glycol, pentylene glycols such as 1,2-pentanediol and 1,5-pentanediol, hexanediols such as 1, 6-hexanediol, hexanetriols such as 1, 2,6-hexanetriol, 1, 2-octanediol, 1, 8-octanediol, dipropylene glycol, tripropylene glycol, diglycerol
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that the at least one water-soluble polyhydric C 2 -C 9 -alkanol having 2 to 6 hydroxyl groups and / or at least one water-soluble polyethylene glycol having 3 to 20 ethylene oxide units in total amounts of 3 - 30 wt .-%, preferably 8 - 25 wt .-%, particularly preferably 10-18 wt .-%, each based on the total composition, is included.
  • compositions according to the invention contain water.
  • the proportion of water is preferably 0.1-99 wt .-%, particularly preferably 3 to 80 wt .-%, most preferably 10 to 70 wt .-%, further preferably 15 - 60 wt .-%, 20 - 50 wt .-%, 30- 40 wt .-%, each based on the total composition.
  • deodorant or antiperspirant compositions are characterized in that at least one wax component with a melting point in the range of 25 - ⁇ 50 0 C, selected from Kokosfett Textreglycerin- mono-, di- and tri-esters, Butyrospermum Parkii (Shea butter) and esters of saturated, monohydric C 8 -C 8 -alcohols with saturated Ci 2 -C- 8 monocarboxylic acids and mixtures of these substances, is included.
  • These lower melting wax components allow consistency optimization of sticky or creamy products and minimization of visible skin residue.
  • coco glycerides in particular the commercial products Novata ® (ex Cognis), particularly preferably Novata AB ®, a mixture of C 12 -C 18 mono-, di- and triglycerides, which in the range of 30-32 ° C, as well as the products of the Softisan series (Sasol Germany GmbH) with the INCI name Hydrogenated Cocoglycerides, in particular Softisan 100, 133, 134, 138, 142.
  • Further preferred esters of saturated, monovalent C 12 -C 18 -alcohols with saturated C 12 -C 18 -monocarboxylic acids are stearic ryllaurat, cetearyl (z. B. Crodamol ® CSS), cetyl palmitate (z. B. Cutina ® CP) and myristyl myristate (z. B. Cetiol ® MM).
  • DEodorant or antiperspirant according to the invention are characterized in that the at least one wax component with a melting point in the range of 25 - ⁇ 50 0 C in amounts of 0.01 to 20 weight %, preferably 3 - 20 wt .-%, particularly preferably 5 - 18 wt .-% and most preferably 6 - 15 wt .-%, based on the total composition, is included.
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that they further contain at least one solid, water-insoluble particulate filler for improving the pen consistency and the sensory properties.
  • this filler is selected from optionally modified starches (for. Example, of corn, rice, potatoes) and starch derivatives, which are, if desired, pregelatinized, in particular starch derivatives, such as Aluminum Starch Octenylsuccinate (z. B. DRY FLO ®) Sodium Starch Octenyl succinates, cellulose and cellulose derivatives, silica, silicas, e.g.
  • Aerosil ® types spherical Polyalkylsesquisiloxan particles (especially Aerosil ® R972 and Aerosil ® 200V from Degussa), silica gels, talc, kaolin, clays, z. Bentonites, magnesium aluminum silicates, boron nitride, lactoglobulin derivatives, e.g. B. Sodium-C 8 -i 6 -sloalkylsuccinyllacto- globulinsulfonat, available from Brooks Industries as a commercial product Biopol ® OE, glass powders, polymer powders, in particular from polyolefins, polycarbonates, polyurethanes, polyamides, eg. As nylon, polyesters, polystyrenes, polyacrylates, (meth) acrylate or (meth) acrylate-vinylidene copolymers, which may be crosslinked, or silicones, and mixtures of these substances.
  • Polymer powder based on a polymethacrylate copolymer are z. B. as a commercial product Polytrap ® 6603 (Dow Corning) available.
  • Other polymer powders e.g. Example based on polyamides, obtainable under the name Orgasol ® 1002 (polyamide-6) and Orgasol ® 2002 (polyamide-12) from Elf Atochem.
  • Other polymer powders which are suitable for the purpose according to the invention are, for. B.
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that they contain at least one solid, water-insoluble particulate filler in a total amount of 0.01 to 30% by weight, preferably 5 to 20% by weight, more preferably 8 to 15 Wt .-%, each based on the total composition included. fragrances
  • perfume component perfumes perfume oils or perfume oil ingredients can be used.
  • perfume oils or fragrances can according to the invention individual fragrance compounds, eg. As the synthetic products of the ester type, ethers, aldehydes, ketones, alcohols and hydrocarbons. Fragrance compounds of the ester type are e.g.
  • the ethers include, for example, benzyl ethyl ether and ambroxane, to the aldehydes e.g.
  • the linear alkanals of 8 - 18 C atoms citral, citronellal, citronellyloxy-acetaldehyde, cyclamen aldehyde, lilial and bourgeonal, to the ketones e.g. the ionones, alpha-lsomethylionone and methylcedryl ketone, the alcohols anethole, citronellol, eugenol, geraniol, linalool, phenylethyl alcohol and terpineol, the hydrocarbons mainly include the terpenes such as limonene and pinene. Preferably, however, mixtures of different fragrances are used, which together produce an attractive fragrance.
  • perfume oils may also contain natural fragrance mixtures such as are available from vegetable sources, e.g. Pine, citrus, jasmine, patchouly, rose or ylang-ylang oil. Also suitable are Muskateller sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, lime blossom oil, juniper berry oil, vetiver oil, olibanum oil, galbanum oil and labdanum oil and orange blossom oil, neroli oil, orange peel oil and sandalwood oil.
  • a fragrance In order to be perceptible, a fragrance must be volatile, whereby besides the nature of the functional groups and the structure of the chemical compound, the molecular weight also plays an important role. For example, most odorants have molecular weights up to about 200 daltons, while molecular weights of 300 daltons and above are more of an exception.
  • the smell of a perfume or fragrance composed of several fragrances changes during evaporation, whereby the odor impressions in "top note", “middle note or body”
  • the top note of a perfume or fragrance consists not only of volatile compounds, while the base note for the most part from less volatile
  • volatile fragrances can be bound to certain fixatives, which prevents them from evaporating too quickly the Odor impression and whether the corresponding fragrance is perceived as the head or middle note, nothing said.
  • Adhesive-resistant fragrances which can be used in the context of the present invention are, for example, the essential oils such as angelica root oil, aniseed oil, arnica blossom oil, basil oil, bay oil, bergamot oil, Champacablütenöl, Edeltannenöl, Edeltannenzapfen oil, Elemiöl, eucalyptus oil, fennel oil, spruce needle oil, galbanum oil, geranium oil, Ginger Grass Oil, Guajac Wood Oil, Gurjun Balm Oil, Helichrysum Oil, Ho Oil, Ginger Oil, Iris Oil, Cajeput Oil, Calam Oil, Chamomile Oil, Camphor Oil, Kanaga Oil, Cardamom Oil, Cassia Oil, Pine Needle Oil, Kopa ⁇ vabalsam Oil, Coriander Oil, Spearmint Oil, Cumin Oil, Cumin Oil, Lavender Oil, Lemongrass Oil, Lime Oil, Tangerine Oil, Melissa Oil, Musk Grain Oil, Myrrh Oil, Clove Oil
  • fragrances can be used in the context of the present invention as adherent fragrances or fragrance mixtures, ie fragrances.
  • These compounds include the following compounds and mixtures thereof: ambrettolide, ⁇ -amylcinnamaldehyde, anethole, anisaldehyde, anisalcohol, anisole, methyl anthranilate, acetophenone, benzylacetone, benzaldehyde, benzoic acid ethyl ester, benzophenone, benzyl alcohol, benzyl acetate, benzyl benzoate, benzyl formate, benzyl valeria nat, borneol, bornyl acetate, ⁇ -bromostyrene, n-decyl aldehyde, n-dodecyl aldehyde, eugenol, eugenol methyl ether, euca
  • the more volatile fragrances include in particular the lower-boiling fragrances of natural or synthetic origin, which can be used alone or in mixtures.
  • Examples of more readily volatile fragrances are alkyl isothiocyanates (alkyl mustard oils), butanedione, limonene, Linalool, linayl acetate and propionate, menthol, menthone, methyl-n-heptenone, phellandrene, phenylacetaldehyde, terpinyl acetate, citral, citronellal.
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that at least one perfume component is contained in a total amount of 0.00001 to 4 wt .-%, preferably 0.5 to 2 wt .-%, each based on the total composition ,
  • compositions according to the invention are characterized in that they contain, in addition to the two-part combination of a) at least one deodorant or antiperspirant active ingredient and b) at least one active ingredient selected from taurine and its physiologically tolerated salts, esters and amides, and mixtures thereof, further containing at least one skin-soothing agent.
  • Skin-soothing active ingredients preferred according to the invention are selected from allantoin, ⁇ -bisabolol, ⁇ -lipoic acid, extracts from Centella asiatica, for example obtainable under the name Madecassicoside from DSM, glycyrrethic acid, which is particularly preferably encapsulated in liposomes and in this form z. B.
  • Extracts of the seeds of Cucurbita pepo which are particularly preferred according to the invention are described, for example, in the commercial products Curbilene (ex lndena SpA, INCI: Cucurbita pepo (pumpkin seed extract), Ocaline (ex Soliance, INCI: Sea Water (and) Water (and ) Cucurbita pepo (pumpkin seed extract), ARP 100 (ex Greentech, INCI: Water, Alcohol, Serenoa Serrulata Fruit Extract, Epilobium Angustifolium Extract, Cucurbita Pepo (Pumpkin) Seed Extract), ARP 100 Huileux (ex Greentech, INCI : Caprylic / Capric Triglycerides, Serenoa Serrulata Fruit Extract, Epilobium Angustifolium Flower / Leaf / Stem Extract, Cucurbita Pepo (Pumpkin) Seed Extract), Cucurbitine (ex Christian Dior Perfumes, INCI: Water (and) Cucurbita
  • Mentha piperita extracts which are particularly preferred according to the invention, in particular from the leaves of Mentha piperita, are described, for example, in the commercial products Calmiskin OP (ex Silab, INCI: Water (and) Mentha piperita (Peppermint Leaf Extract) and Caomint (ex Solabia, INCI: Propylene Glycol, Water, Mentha piperita (Peppermint) leaf extract, Theobroma cacao (Cocoa) extract).
  • Extremely preferred according to the invention is allantoin; Extremely preferred compositions according to the invention contain at least one deodorant or antiperspirant active ingredient, taurine and allantoin.
  • At least one skin-soothing active ingredient is preferably in a total amount of 0.001 to 5 wt .-%, particularly preferably 0.01 to 2 wt .-% and exceptionally preferably 0.05 to 1 wt .-%, in each case on the entire composition, included.
  • the skin soothing effect was increased and improved by combinations of taurine or taurine derivatives with vegetable oils, in particular with olive oil, to an unexpected extent and improved.
  • compositions according to the invention are characterized in that they contain, in addition to the two-part combination of a) at least one deodorant or antiperspirant active ingredient and b) at least one active ingredient selected from taurine and its physiologically tolerated salts, esters and amides, and mixtures thereof, furthermore at least one vegetable oil which does not constitute a perfume, in particular olive oil.
  • Vegetable oils which are not fragrance preferred according to the invention are selected from olive oil, sunflower oil, soybean oil, rapeseed oil, almond oil, jojoba oil, orange oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil, lanolin and its derivatives. Olive oil is particularly preferred.
  • compositions according to the invention contain at least one deodorant or antiperspirant active ingredient, taurine and olive oil.
  • the vegetable oil is preferably contained in a total amount of 0.1-5 wt .-%, particularly preferably 0.5 to 2 wt .-% and most preferably 1 - 2 wt .-%, each based on the total composition.
  • compositions according to the invention comprise at least one deodorant or antiperspirant active ingredient, taurine, allantoin and olive oil.
  • Antiperspirant sticks according to the invention based on an oil-in-water emulsion (amounts in% by weight)
  • the emulsion according to Example 8 had the first day after the preparation has a viscosity of 2200 mPas, measured with a Brookfield viscometer, spindle RV 4, 20 s-1 without Helipath, at 20 0 C ambient temperature and 20 0 C sample temperature; she was filled into a roll-on applicator.
  • Example 9 Antiperspirant Emulsion (O / W) According to the Invention
  • the emulsion according to Example 9 had the first day after the preparation has a viscosity of 1700 mPas, measured with a Brookfield viscometer, spindle RV 4, 20 s-1 without Helipath, at 20 0 C ambient temperature and 20 0 C sample temperature; she was filled into a roll-on applicator.
  • Soap-containing pens (in% by weight)
  • Anhydrous deodorant spray (in% by weight)
  • Suspension type antiperspirant spray (in% by weight)
  • Antiperspirant Wipes (Examples Nos. 17.1 - 17.4)
  • a single-layer substrate made of 100% rayon with a basis weight of 50 g / m 2 with 75 g of the example emulsions 11.1 and 11.2 or 2.3 per square meter or with 75 g of the sample solutions 13.1 and 13.2, cut into cloths of suitable size and packed in sachets.
  • Example Composition 19.1 contains an antiperspirant emulsion according to the invention with 9.9% by weight aluminum chlorohydrate, based on the weight of the propellant-free emulsion. With a spray rate of 0.35 g / s, 0.035 g of the antiperspirant active ingredient aluminum chlorohydrate are sprayed onto the skin surface every second.
  • Example Composition 19.2 contains an antiperspirant emulsion according to the invention with 17.49% by weight aluminum chlorohydrate, based on the weight of the propellant-free emulsion. At a spray rate of 0.2 g / s, 0.035 g of the antiperspirant active ingredient aluminum chlorohydrate is sprayed onto the skin surface every second.
  • compositions according to the invention are applied to the skin, in particular the underarm skin.
  • compositions according to the invention are distinguished by a high level of skin tolerance which is improved in comparison with the prior art and by reduced skin burning and / or reduced itching during and after application to the skin.
  • the refractive index of the water phase must be adapted to the refractive index of the oil phase.
  • Water or propylene glycol serve as a variable The better the refractive index approximation (if possible to +/- 0.0003 exactly and better), the more transparent the overall composition.
  • the thickener (carbomer) should be adjusted to the desired pH with a suitable neutralizing agent (triethanolamine (TEA), AMINOMETHYL PROPANOL (AMP), NaOH, LiOH).
  • a suitable neutralizing agent triethanolamine (TEA), AMINOMETHYL PROPANOL (AMP), NaOH, LiOH.
  • TAA triethanolamine
  • AMP AMINOMETHYL PROPANOL
  • NaOH LiOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne des compositions cosmétiques et dermatologiques antitranspirantes et désodorisantes, lesdites compositions présentant un potentiel irritatif réduit et contenant au moins une substance active choisie parmi la taurine et ses sels, esters et amides physiologiquement acceptables, ainsi que ses mélanges.
EP07847981A 2006-12-27 2007-12-07 Compositions antitranspirantes et désodorisantes de potentiel irritatif réduit Withdrawn EP2059225A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006062433A DE102006062433A1 (de) 2006-12-27 2006-12-27 Antitranspirant- und Deodorant-Zusammensetzungen mit verringertem Reizpotenzial
PCT/EP2007/063528 WO2008080764A1 (fr) 2006-12-27 2007-12-07 Compositions antitranspirantes et désodorisantes de potentiel irritatif réduit

Publications (1)

Publication Number Publication Date
EP2059225A1 true EP2059225A1 (fr) 2009-05-20

Family

ID=39111518

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07847981A Withdrawn EP2059225A1 (fr) 2006-12-27 2007-12-07 Compositions antitranspirantes et désodorisantes de potentiel irritatif réduit

Country Status (3)

Country Link
EP (1) EP2059225A1 (fr)
DE (1) DE102006062433A1 (fr)
WO (1) WO2008080764A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2295114A1 (fr) 2009-09-10 2011-03-16 Dalli-Werke GmbH & Co. KG Composition cosmétique dotée d'un effet antimicrobien
DE102013216381A1 (de) 2013-08-19 2015-02-19 Henkel Ag & Co. Kgaa juckreizverminderte Antitranspirantien
AU2016406769B2 (en) 2016-05-10 2019-02-07 Colgate-Palmolive Company Taurine and aloe synergistic anti-irritant compositions and methods
RU2735830C1 (ru) * 2017-12-12 2020-11-09 Колгейт-Палмолив Компани Композиция для личной гигиены
CN117449037B (zh) * 2023-12-26 2024-03-15 江苏青昀新材料有限公司 一种闪纺膜材及其制造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1597497A (en) * 1977-04-26 1981-09-09 Unilever Ltd Antiperspirants
US4302443A (en) * 1980-02-21 1981-11-24 Terry Corporation Non-irritating antiperspirant
GB8410403D0 (en) * 1984-04-24 1984-05-31 Unilever Plc Antiperspirant product
DE19756454C1 (de) 1997-12-18 1999-06-17 Henkel Kgaa Verwendung von Glycerincarbonat
DE19921752A1 (de) * 1999-05-07 2000-11-09 Toni Gradl Stoff zum Abbau von apokrinem Schweiß auf der menschlichen Haut, Deodorant hergestellt unter Verwendung dieses Stoffes sowie Verfahren zum Abbau von apokrinem Schweiß auf der menschlichen Haut
DE10002643A1 (de) * 2000-01-21 2001-07-26 Cognis Deutschland Gmbh Desodorierende Zubereitungen
FR2828646B1 (fr) * 2001-08-17 2004-11-26 Oreal Stick antitranspirant anhydre
US20030206973A1 (en) * 2002-05-01 2003-11-06 Carolyn Gale All natural gentle deodorant and antiperspirant
DE102004011968A1 (de) 2004-03-10 2005-09-29 Henkel Kgaa Präbiotisch wirksame Pflanzenextrakte
DE10333245C5 (de) 2003-07-21 2015-02-19 Henkel Ag & Co. Kgaa Präbiotisch wirksame Pflanzenextrakte
US20060127342A1 (en) * 2004-12-09 2006-06-15 Georgia Levis Taurine-based compositions, therapeutic methods, and assays
DE102005022625A1 (de) * 2005-05-11 2006-11-23 Henkel Kgaa Verwendung von Taurin zur Steigerung der epidermalen Lipidsynthese

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2008080764A1 *

Also Published As

Publication number Publication date
WO2008080764A1 (fr) 2008-07-10
DE102006062433A1 (de) 2008-07-03

Similar Documents

Publication Publication Date Title
EP1773454B1 (fr) Stick deodorant ou antitranspirant sans traces a base d'une dispersion huile dans eau
EP2056789A1 (fr) Compositions anti-transpiration et déodorantes ayant une action de soin améliorée
DE102010063250A1 (de) Wasserhaltige Antitranspirant-Zusammensetzungen mit verbesserter Rückstandsmaskierung
DE102006004957A1 (de) Rückstandsarmer Deodorant- oder Antitranspirant-Stift auf Basis einer Öl-in-Wasser-Dispersion/Emulsion
DE102012222692A1 (de) Antibakterielles Kosmetikum
DE102009029423A1 (de) Antibakterielle kosmetische oder pharmazeutische, zur Körperdeodorierung geeignete Zusammensetzungen gegen Körpergeruch
DE102005029777A1 (de) Rückstandsarmer Deodorant- oder Antitranspirant-Stift auf Basis einer ethanolhaltigen Öl-in-Wasser-Dispersion
DE102009027604A1 (de) Kosmetische Zusammensetzungen mit Suspensionen von Silbersalzen
DE102010027947A1 (de) Hautschonende Deodorantien und Antitranspirantien
WO2009101000A2 (fr) Déodorants et/ou antitranspirants à fragrance et à capacité d'absorption d'odeurs à effet renforcé
EP2370050B1 (fr) Nouveaux déodorants et anti-transpirants permettant d'inhiber la croissance pileuse
DE102017215322A1 (de) Polyethylenimin mit geringem Molekulargewicht als Antitranspirant-Wirkstoff
EP2059225A1 (fr) Compositions antitranspirantes et désodorisantes de potentiel irritatif réduit
DE102016220085A1 (de) geruchsreduzierende Körperpflegemittel
EP2884958B1 (fr) Compositions cosmétiques à libération retardée des actifs
WO2010145921A2 (fr) Compositions cosmétiques contenant des sels d'argent sélectionnés
EP2442780B1 (fr) Compositions cosmétiques contenant du lactate d'argent
WO2014187576A1 (fr) Association de principes actifs désodorisante
DE102011088967A1 (de) Deodorants und Antitranspirants mit stabilisiertem Antioxidans
DE102005029776A1 (de) Rückstandsarmer Deodorant- oder Antitranspirant-Stift auf Basis einer Öl-in-Wasser-Dispersion
DE102018203044A1 (de) Poly(Vinylamin-Vinylformamid)-copolymere als Antitranspirant-Wirkstoff
EP2442781B1 (fr) Compositions cosmétiques contenant du sulfate d'argent
DE102011087980A1 (de) Deodorants und Antitranspirants mit Haar aufhellender Wirkung
DE102007024383A1 (de) Antibakterielle Deodorantien und/oder Antitranspirantien
DE102006021780A1 (de) Rückstandsarmer Deodorant- oder Antitranspirant-Stift auf Basis einer ethanolhaltigen Öl-in-Wasser-Dispersion/Emulsion

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090210

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

RIN1 Information on inventor provided before grant (corrected)

Inventor name: DOERING, THOMAS

Inventor name: HEIDE, BARBARA

Inventor name: BANOWSKI, BERNHARD

Inventor name: WADLE, ARMIN

17Q First examination report despatched

Effective date: 20100323

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100803